Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
INR 67.38
(2.87%)
INR 67.38
(2.87%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -3.71 INR | 36.69% |
| 2022 | -5.86 INR | -4285.71% |
| 2021 | 0.14 INR | 54.7% |
| 2020 | 0.09 INR | 178.46% |
| 2019 | 0.03 INR | 119.12% |
| 2018 | -0.17 INR | 84.96% |
| 2017 | -1.13 INR | -453.13% |
| 2016 | 0.32 INR | 127.35% |
| 2015 | -1.17 INR | -515.79% |
| 2014 | -0.19 INR | 81.73% |
| 2013 | -1.04 INR | -793.33% |
| 2012 | 0.15 INR | 36.36% |
| 2011 | 0.11 INR | 121.57% |
| 2010 | -0.51 INR | -64.52% |
| 2009 | -0.31 INR | -29.17% |
| 2008 | -0.24 INR | 0.0% |
| 2007 | - INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.76 INR | 70.43% |
| 2023 Q4 | -2.57 INR | -238.16% |
| 2023 Q3 | -0.76 INR | -230.43% |
| 2023 Q2 | -0.23 INR | 62.3% |
| 2023 Q1 | -0.61 INR | 87.18% |
| 2023 FY | - INR | 36.69% |
| 2022 Q2 | -0.42 INR | -200.0% |
| 2022 FY | - INR | -4285.71% |
| 2022 Q3 | -0.68 INR | -61.9% |
| 2022 Q1 | -0.14 INR | -400.43% |
| 2022 Q4 | -4.76 INR | -600.0% |
| 2021 Q4 | 0.05 INR | 366.0% |
| 2021 Q3 | 0.01 INR | -85.71% |
| 2021 FY | - INR | 54.7% |
| 2021 Q1 | 0.01 INR | -76.02% |
| 2021 Q2 | 0.07 INR | 600.0% |
| 2020 Q3 | 0.01 INR | -75.0% |
| 2020 Q1 | 0.00 INR | 0.0% |
| 2020 Q2 | 0.04 INR | 1112.12% |
| 2020 FY | - INR | 178.46% |
| 2020 Q4 | 0.04 INR | 317.0% |
| 2019 FY | - INR | 119.12% |
| 2019 Q1 | -0.20 INR | 0.0% |
| 2019 Q2 | -0.23 INR | -15.0% |
| 2019 Q3 | -0.19 INR | 17.39% |
| 2019 Q4 | - INR | 100.0% |
| 2018 FY | - INR | 84.96% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q3 | 0.10 INR | 137.04% |
| 2018 Q2 | -0.27 INR | -145.45% |
| 2018 Q1 | -0.11 INR | -25.71% |
| 2017 Q4 | -0.09 INR | 63.54% |
| 2017 FY | - INR | -453.13% |
| 2017 Q3 | -0.24 INR | 7.69% |
| 2017 Q2 | -0.26 INR | 51.85% |
| 2017 Q1 | -0.54 INR | -208.0% |
| 2016 Q2 | -0.14 INR | -180.0% |
| 2016 Q1 | -0.05 INR | 91.53% |
| 2016 Q4 | 0.50 INR | 933.33% |
| 2016 Q3 | -0.06 INR | 57.14% |
| 2016 FY | - INR | 127.35% |
| 2015 Q1 | 0.15 INR | 0.0% |
| 2015 FY | - INR | -515.79% |
| 2015 Q2 | -0.18 INR | -220.0% |
| 2015 Q3 | -0.65 INR | -261.11% |
| 2015 Q4 | -0.59 INR | 9.23% |
| 2014 Q1 | 0.05 INR | 0.0% |
| 2014 Q4 | - INR | -100.0% |
| 2014 Q2 | 0.07 INR | 40.0% |
| 2014 FY | - INR | 81.73% |
| 2014 Q3 | 0.05 INR | -28.57% |
| 2013 FY | - INR | -793.33% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 0.08 INR | 0.0% |
| 2013 Q2 | 0.08 INR | 60.0% |
| 2013 Q1 | 0.05 INR | 0.0% |
| 2012 Q3 | 0.08 INR | 300.0% |
| 2012 Q1 | 0.03 INR | 185.96% |
| 2012 Q4 | - INR | -100.0% |
| 2012 FY | - INR | 36.36% |
| 2012 Q2 | 0.02 INR | -33.33% |
| 2011 Q3 | 0.12 INR | 0.0% |
| 2011 FY | - INR | 121.57% |
| 2011 Q4 | -0.03 INR | -129.08% |
| 2010 Q4 | -0.23 INR | 0.0% |
| 2010 FY | - INR | -64.52% |
| 2009 Q4 | -0.09 INR | 0.0% |
| 2009 FY | - INR | -29.17% |
| 2008 FY | - INR | 0.0% |
| 2008 Q4 | -0.06 INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | - INR | 0.0% |